MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Personnel moves: Former FDA commissioner Eschenbach elected to Viamet board

Personnel moves: Former FDA commissioner Eschenbach elected to Viamet board

By

Personnel roundup

Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation.

  • Former FDA commissioner Andrew von Eschenbach elected to Viamet board
    Viamet Pharmaceuticals Inc., which discovers and develops inhibitors of key metalloenzymes, announced that Andrew von Eschenbach, M.D., former Food & Drug Administration commissioner and former director of the U.S. National Cancer Institute (NCI), has joined the company’s board. Dr. von Eschenbach is a recognized leader in urology, prostate cancer research, patient healthcare policy and pharmaceutical regulation.
    Read more

  • NIMHD names first African-American scientific director at NIH
    The National Institute on Minority Health and Health Disparities announced the appointment of William G. Coleman, Jr., Ph.D., as the NIMHD’s first permanent scientific director and the first African-American scientific director in the history of the NIH Intramural Research Program. The appointment follows an extensive national search. Dr. Coleman is one of 23 scientific directors at the NIH.
    Read more

  • Lantheus promotes Robert Gaffey to CFO
    Lantheus Medical Imaging Inc., a worldwide company in diagnostic imaging, announced the promotion of Robert Gaffey to CFO. He was most recently vice president, Finance and IT. In this expanded role, Mr. Gaffey will add the leadership for investor relations and strategic corporate communications to his current responsibilities of directing the Company’s global financial strategy. Mr. Gaffey will continue to report to Lantheus President and CEO, Don Kiepert.
    Read more

  • Solta Medical Inc. appoints Thomas Yorkey to VP of R&D
    Solta Medical Inc. (NSDQ:SLTM), a global leader in the medical aesthetics market, announced the promotion of Thomas Yorkey, Ph.D., to VP of Research & Development, Dr. Yorkey will lead all global R&D initiatives and will report to Clint Carnell, COO at Solta.
    Read more

  • AxoGen signs Brad Hedger as VP of sales
    AxoGen Inc. announced hiring Brad Hedger as VP of Sales. This is a new position within AxoGen signifying the continued, aggressive sales growth of the organization.
    Read more

  • Dr. Peter Pronovost to join the board of Cantel Medical Corp.
    Cantel Medical Corp. (NYSE:CMN) announced the election of Peter J. Pronovost, M.D., Ph.D. to serve as an independent member of Cantel’s board.
    Read more

  • ICTS Patient Recruitment announces board changes
    ICTS, the patient recruitment and clinical trial marketing services company, announced that Sheila H. Ogle, CEO of ICTS, has resigned from the company after 8 years of service. Ogle made the announcement at the ICTS board meeting in December.
    Read more

  • New CEO appointed to MedTech Holdings
    MedTech Holdings Inc. a components and contract medical device manufacturer, announced that its board has named Dan Croteau, 45, to serve as the company’s CEO. Croteau succeeds George W. Blank, MedTech’s founding CEO. Blank will assume the role of Chairman of the board of MedTech Holdings.
    Read more

  • DJO Inc. announces planned transition of president and CEO Les Cross
    DJO Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, announced the planned retirement of Leslie H. Cross, President and CEO.
    Read more

  • Accuray hires chief marketing officer
    Accuray Incorporated (NSDQ:ARAY), a global leader in the field of radiosurgery, announced that Eric Pauwels has joined Accuray as Senior VP and Chief Marketing Officer, effective January 17, 2011.
    Read more

  • Pescatello elected to head New England Biotech Association in 2011-12
    Paul Pescatello has been re-elected as Chairman of the New England Biotech Association (NEBA) at the organization’s annual meeting.
    Read more

  • PrognosDx announces appointments of Dr. Garry Nolan to board and Dr. Joseph Presti to scientific advisory board
    PrognosDx Health Inc., an epigenetics pioneer harnessing the predictive power of global patterns of histone modifications, announced the appointment of Garry P. Nolan, Ph.D. as Vice Chairman.
    Read more

  • Cenduit sales executive appointed to expand business development
    Cenduit, a provider of Interactive Response Technology solutions (IVRS/IWRS) to support multi-continent clinical programs, announced the appointment of Anthony Frankland as the Global Head of Sales and Marketing. Cenduit, a joint venture between Thermo Fisher Scientific and Quintiles, opens the door to a new level of clinical trial support by acting as the central conduit of data between clinical supplies and clinical development.
    Read more

  • WaferGen appoints clinical genomics cancer researcher Dr. Arul M. Chinnaiyan to scientific advisory board
    WaferGen Biosystems Inc. (OTC:WGBS), a developer of state-of-the-art genomic analysis systems, announced that it has appointed world-renowned clinical genomics cancer researcher Arul M. Chinnaiyan, M.D., Ph.D., to its scientific advisory board.
    Read more

  • Foundation Medicine appoints Gary Palmer VP, medical affairs and commercial development
    Diagnostics company Foundation Medicine Inc. named Gary Palmer as senior VP, medical affairs and commercial development. The role is a newly created position in which Palmer will see through the startup’s cancer tests into clinical tests and commercial development, according to Mass High Tech.
    Read more

  • Transenterix lands surgical device executive to serve as CTO
    Richard M. Mueller has been named CTO at TransEnterix.
    Read more

  • Human Genome Sciences appoints Greg Norden to board
    Human Genome Sciences Inc. (NSDQ:HGSI) announced that Greg Norden, former Senior VP and CFO of Wyeth, has been appointed to the HGS board.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Texas power grid struggles in heat one year after record cold stopped semiconductor plants
    A heat wave in Texas took at least six power plants offline Friday with high temperatures forecasted to blaze throughout this week. A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production. There’s no… […]
  • How Stryker includes users for product design in the digital age
    Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial. Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them. The DeviceTalks Boston panel of Stryker… […]
  • DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event
    DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event.  The Miami-based mid-stage company beat out 1,000 applicants, more than 20 of which competed on-site May 10–11, 2022 at DeviceTalks Boston. DermaSensor walked away with… […]
  • Steris rises on Street-beating Q4, sets fiscal 2023 guidance
    Steris (NYSE:STE) shares ticked up today on fourth-quarter financial results that came in just ahead of the consensus forecast. The infection prevention technology company — headquartered in Dublin, Ireland, and run operationally out of Mentor, Ohio — posted profits of $52.3 million, or 52¢ per share, on sales of $1.2 billion for the three months… […]
  • Lucira Health asks FDA for EUA on molecular at-home COVID/flu test
    Lucira Health (Nasdaq: LHDX) today said it has asked the FDA for an emergency use authorization (EUA) for its combination COVID-19 and flu test. Emeryville, California–based Lucira said the at-home test would be available with a prescription to test for SARS-CoV-2, Influenza A and Influenza B. The Nucleic Acid Amplification Test (NAAT) platform has a… […]
  • Device commercialization platform AcuityMD raises $31M Series A to fund R&D engineer hiring
    AcuityMD said today it has raised $31 million in Series A funding for its medical device commercialization platform. “With our new funding, we plan to double down on R&D by growing our engineering team from 15 to over 40 over the next year,” AcuityMD co-founder and CEO Michael Monovoukas said in a blog post. “We’ll… […]
  • Rockley Photonics announces $81.5M private placement
    Rockley Photonics (NYSE:RKLY) announced today that it entered into agreements for an $81.5 million private placement. Participating investors agreed to purchase $81.5 million in convertible senior secured notes (due 2026) and warrants to purchase 26.5 million Rockley ordinary shares at an exercise price of $5 per share, subject to certain anti-dilution adjustments. Warrants purchased in… […]
  • Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’
    The first day of DeviceTalks Boston closed with a panel of Stryker (NYSE:SYK) executives discussing new tools, technologies and strategies in medtech. Digital VP Tracy Robertson, Digital, Robotics, and Enabling Technologies President Robert Cohen and Surgical Technologies VP of Digital Innovation Siddarth Satish offered their thoughts on industry trends in healthcare and at the Kalamazoo,… […]
  • Medtronic’s VC leader discusses risk, returns, strategy and an ‘ugly truth’
    A panel of medtech investors convened today for DeviceTalks Boston included David Neustaedter, VP of venture capital at Medtronic (NYSE: MDT). He’s spent 14 years in the role, including as director of venture capital at Covidien before Medtronic acquired the company. (Read more in his DeviceTalks speaker bio.) Medtronic has more than $500 million in… […]
  • Here’s where Harvard’s engineering dean sees medtech research going
    Surgical robotics, artificial intelligence, and combatting climate change are but some of the priorities that have Harvard’s engineering school dean excited. Speaking today at DeviceTalks Boston, Frank J. Doyle III described the Harvard John A. Paulson School of Engineering and Applied Sciences as a “well-kept secret” historically. But Harvard engineering is staking out a strong position when it… […]
  • gBETA Medtech accelerator picks its next startups
    The gBETA Medtech virtual accelerator today named the five startups that will participate in the spring program leading up to the June 21 showcase day. The five startups for the spring 2022 cohort are: Mother of Fact: This mobile app for moms with babies offers nutrition tracking, preventative monitoring and daily coaching from licensed dietitians… […]

Leave a Reply